Waters announce new LC–MS test method for SARS-CoV-2 and other infectious diseases

Written by Vivian Xie

A new research use only LC–MS method has been introduced by Waters Corporation (MA, USA) with the goal of advancing critical infectious disease research, including the continuing fight against COVID-19. Highly sensitive, the novel detection method can detect low levels of three unique peptides derived from the SARS-CoV-2 nucleocapsid protein in less than 2 minutes. Initial studies have shown the quantitative results to be highly accurate. Such sensitive detection methods are made possible by an innovative antipeptide antibody enrichment sample preparation method, as well as antibodies from SISCAPA Assay Technologies (CA, USA). This improves the performance of the mass spectrometry...

To view this content, please register now for access

It's completely free